The state of personalized treatment for anxiety disorders: A systematic review of treatment moderators

Clinical Psychology Review

Volumn 38, Issue , 2015, Pages 39-54

  Schneider, Rebecca L ^a   Arch, Joanna J ^a   Wolitzky Taylor, Kate B ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Anxiety disorders; Cognitive behavioral therapy; Moderators; Personalized medicine; Treatment moderation; Treatment outcome

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ANXIETY DISORDER; BEHAVIOR THERAPY; COGNITIVE THERAPY; COMORBIDITY; EMOTIONAL DISORDER; HUMAN; OBSESSIVE COMPULSIVE DISORDER; PERSONALITY; PERSONALITY DISORDER; POSTTRAUMATIC STRESS DISORDER; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SAMPLE SIZE; SOCIAL ASPECT; SOCIAL STATUS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ANXIETY DISORDERS; PERSONALIZED MEDICINE; PROCEDURES; PSYCHOLOGY; STRESS DISORDERS, POST-TRAUMATIC;

ANXIETY DISORDERS; COGNITIVE THERAPY; HUMANS; PRECISION MEDICINE; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 84924854083     PISSN: 02727358     EISSN: 18737811     Source Type: Journal    
DOI: 10.1016/j.cpr.2015.02.004     Document Type: Review

References (73)

1. Aiken L.S., West S.G. Multiple regression: Testing and interpreting interactions 1991, Sage Publications, Newbury Park, Calif.
2. Andersson G., Carlbring P., Grimlund A. Predicting treatment outcome in internet versus face to face treatment of panic disorder. Computers in Human Behavior 2008, 24(5):1790-1801. 10.1016/j.chb.2008.02.003.
3. Arch J.J., Ayers C.R. Which treatment worked better for whom? Moderators of group cognitive behavioral therapy versus adapted mindfulness based stress reduction for anxiety disorders. Behaviour Research and Therapy 2013, 51(8):434-442. 10.1016/j.brat.2013.04.004.
4. Arch J.J., Craske M.G. Acceptance and commitment therapy and cognitive behavioral therapy for anxiety disorders: Different treatments, similar mechanisms?. Clinical Psychology: Science and Practice 2008, 15(4):263-279.
5. Arch J.J., Craske M.G. First-line treatment: A critical appraisal of cognitive behavioral therapy developments and alternatives. Psychiatric Clinics of North America 2009, 32(3):525-547. 10.1016/j.psc.2009.05.001.
6. Barlow D.H., Allen L.B., Choate M.L. Toward a unified treatment for emotional disorders. Behavior Therapy 2004, 35(2):205-230. 10.1016/s0005-7894(04)80036-4.
7. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology 1986, 51(6):1173. 10.1037/0022-3514.51.6.1173.
8. Brody A.L., Saxena S., Schwartz J.M., Stoessel P.W., Maidment K., Phelps M.E., et al. FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Research 1998, 84(1):1-6. 10.1016/s0925-4927(98)00041-9.
9. Burton M., Schmertz S.K., Price M., Masuda A., Anderson P.L. The relation between mindfulness and fear of negative evaluation over the course of cognitive behavioral therapy for social anxiety disorder: The relation between mindfulness and fear. Journal of Clinical Psychology 2013, 69(3):222-228. 10.1002/jclp.21929.
10. Butler A., Chapman J., Forman E., Beck A. The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clinical Psychology Review 2006, 26(1):17-31. 10.1016/j.cpr.2005.07.003.
11. Chambless D.L., Baker M.J., Baucom D.H., Beutler L.E., Calhoun K.S., Crits-Christoph P., et al. Update on empirically validated therapies, II. Clinical Psychologist 1998, 51(1):3-16. 10.1037/e619622010-001.
12. Chambless D.L., Ollendick T.H. Empirically supported psychological interventions: Controversies and evidence. Annual Review of Psychology 2001, 52:685-716. 10.1146/annurev.psych.52.1.685.
13. Chambless D.L., Sanderson W.C., Shoham V., Bennett Johnson S., Pope K.S., Crits-Christoph P., et al. An update on empirically validated therapies. The Clinical Psychologist 1996, 49:5-18. 10.1037/e555332011-003.
14. Cottraux J., Mollard E., Bouvard M., Marks I., Sluys M., Nury A.M., et al. A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. International Clinical Psychopharmacology 1990, 5(1):17-30. 10.1097/00004850-199001000-00002.
15. Craske M.G., Niles A.N., Burklund L.J., Wolitzky-Taylor K.B., Vilardaga J.C.P., Arch J.J., et al. Randomized controlled trial of cognitive behavioral therapy and acceptance and commitment therapy for social phobia: Outcomes and moderators. Journal of Consulting and Clinical Psychology 2014, 82(6):1034-1048. 10.1037/a0037212.
16. Craske M.G., Rauch S.L., Ursano R., Prenoveau J., Pine D.S., Zinbarg R.E. What is an anxiety disorder?. Depression and Anxiety 2009, 26(12):1066-1085. 10.1002/da.20633.
17. D'Alcante C.C., Diniz J.B., Fossaluza V., Batistuzzo M.C., Lopes A.C., Shavitt R.G., et al. Neuropsychological predictors of response to randomized treatment in obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012, 39(2):310-317. 10.1016/j.pnpbp.2012.07.002.
18. Davies C.D., Niles A.N., Pittig A., Arch J.J., Craske M.G. Physiological and behavioral indices of emotion dysregulation as predictors of outcome from cognitive behavioral therapy and acceptance and commitment therapy for anxiety. Journal of Behavior Therapy and Experimental Psychiatry 2015, 46:35-43. 10.1016/j.jbtep.2014.08.002.
19. de Haan E., van Oppen P., Balkom A., Spinhoven P., Hoogduin K.A.L., van Dyck R. Prediction of outcome and early vs. late improvement in OCD patients treated with cognitive behaviour therapy and pharmacotherapy. Acta Psychiatrica Scandinavica 1997, 96(5):354-361. 10.1111/j.1600-0447.1997.tb09929.x.
20. De Kleine R.A., Hendriks G.-J., Kusters W.J.C., Broekman T.G., van Minnen A. A randomized placebo-controlled trial of d-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biological Psychiatry 2012, 71(11):962-968. 10.1016/j.biopsych.2012.02.033.
21. De Kleine R.A., Hendriks G.-J., Smits J.A.J., Broekman T.G., van Minnen A. Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder. Journal of Psychiatric Research 2014, 48(1):40-46. 10.1016/j.jpsychires.2013.10.008.
22. Dow M.G.T., Kenardy J.A., Johnston D.W., Newman M.G., Taylor C.B., Thomson A. Prognostic indices with brief and standard CBT for panic disorder: II. Moderators of outcome. Psychological Medicine 2007, 37(10). 10.1017/S0033291707000682.
23. El Alaoui S., Hedman E., Ljótsson B., Bergström J., Andersson E., Rück C. Predictors and Moderators of Internet-and Group-Based Cognitive Behaviour Therapy for Panic Disorder. PloS one 2013, 8(11):e79024.
24. Eskildsen A., Hougaard E., Rosenberg N.K. Pre-treatment patient variables as predictors of drop-out and treatment outcome in cognitive behavioural therapy for social phobia: A systematic review. Nordic Journal of Psychiatry 2010, 64(2):94-105. 10.3109/08039480903426929.
25. Ginsburg G.S., Willard H.F. Genomic and personalized medicine: Foundations and applications. Translational Research 2009, 154(6):277-287. 10.1016/j.trsl.2009.09.005.
26. Hansen B., Vogel P.A., Stiles T.C., Gunnar Götestam K. Influence of co-morbid generalized anxiety disorder, panic disorder and personality disorders on the outcome of cognitive behavioural treatment of obsessive-compulsive disorder. Cognitive Behaviour Therapy 2007, 36(3):145-155. 10.1080/16506070701259374.
27. Hedman E., Andersson E., Ljótsson B., Andersson G., Andersson E., Schalling M., et al. Clinical and genetic outcome determinants of Internet- and group-based cognitive behavior therapy for social anxiety disorder. Acta Psychiatrica Scandinavica 2012, 126(2):126-136. 10.1111/j.1600-0447.2012.01834.x.
28. Hicks T.V., Leitenberg H., Barlow D.H., Gorman J.M., Shear M.K., Woods S.W. Physical, mental, and social catastrophic cognitions as prognostic factors in cognitive-behavioral and pharmacological treatments for panic disorder. Journal of Consulting and Clinical Psychology 2005, 73(3):506-514. 10.1037/0022-006X.73.3.506.
29. Hoexter M.Q., Dougherty D.D., Shavitt R.G., D'Alcante C.C., Duran F.L.S., Lopes A.C., et al. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive-compulsive disorder. European Neuropsychopharmacology 2013, 23(7):569-580. 10.1016/j.euroneuro.2012.06.014.
30. Hofmann S.G., Asnaani A., Vonk I.J.J., Sawyer A.T., Fang A. The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research 2012, 36(5):427-440. 10.1037/a0018555.
31. Hofmann S.G., Sawyer A.T., Witt A.A., Oh D. The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review. Journal of Consulting and Clinical Psychology 2010, 78(2):169-183. 10.1037/a0018555.
32. Hofmann S.G., Smits J.A. Cognitive-behavioral therapy for adult anxiety disorders: A meta-analysis of randomized placebo-controlled trials. The Journal of Clinical Psychiatry 2008, 69(4):621. 10.4088/jcp.v69n0415.
33. Hohagen F., Winkelmann G., Rasche-Rüchle H., Hand I., König A., Münchau N., et al. Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo. Results of a multicentre study. The British Journal of Psychiatry. Supplement 1998, (35):71-78.
34. Holmbeck G.N. Post-hoc probing of significant moderational and mediational effects in studies of pediatric populations. Journal of Pediatric Psychology 2002, 27(1):87-96. 10.1093/jpepsy/27.1.87.
35. Insel T.R. Translating scientific opportunity into public health impact: A strategic plan for research on mental illness. Archives of General Psychiatry 2009, 66(2):128-133. 10.1001/archgenpsychiatry.2008.540.
36. Joutsenniemi K., Laaksonen M.A., Knekt P., Haaramo P., Lindfors O. Prediction of the outcome of short- and long-term psychotherapy based on socio-demographic factors. Journal of Affective Disorders 2012, 141(2-3):331-342. 10.1016/j.jad.2012.03.027.
37. Keeley M.L., Storch E.A., Merlo L.J., Geffken G.R. Clinical predictors of response to cognitive-behavioral therapy for obsessive-compulsive disorder. Clinical Psychology Review 2008, 28(1):118-130. 10.1016/j.cpr.2007.04.003.
38. Klass E.T., Milrod B.L., Leon A.C., Kay S.J., Schwalberg M., Li C., et al. Does interpersonal loss preceding panic disorder onset moderate response to psychotherapy? An exploratory study. The Journal of Clinical Psychiatry 2009, 70(3):406-411. 10.4088/JCP.08m04248.
39. Knopp J., Knowles S., Bee P., Lovell K., Bower P. A systematic review of predictors and moderators of response to psychological therapies in OCD: Do we have enough empirical evidence to target treatment?. Clinical Psychology Review 2013, 33(8):1067-1081. 10.1016/j.cpr.2013.08.008.
40. Kraemer H.C. Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: A parametric approach. Statistics in Medicine 2013, 32:1964-1973. 10.1002/sim.5734.
41. Kraemer H.C., Frank E., Kupfer D.J. Moderators of treatment outcomes: Clinical, research, and policy importance. JAMA 2006, 296(10):1286-1289. 10.1001/jama.296.10.1286.
42. Kraemer H.C., Wilson G.T., Fairburn C.G., Agras W.S. Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 2002, 59(10):877. 10.1001/archpsyc.59.10.877.
43. Luborsky L., Auerbach A.H., Chandler M., Cohen J., Bachrach H.M. Factors influencing the outcome of psychotherapy: A review of quantitative research. Psychological Bulletin 1971, 75(3):145.
44. Maher M.J., Huppert J.D., Chen H., Duan N., Foa E.B., Liebowitz M.R., et al. Moderators and predictors of response to cognitive-behavioral therapy augmentation of pharmacotherapy in obsessive-compulsive disorder. Psychological Medicine 2010, 40(12):2013-2023. 10.1017/s0033291710000620.
45. McClelland G.H., Judd C.M. Statistical difficulties of detecting interactions and moderator effects. Psychological Bulletin 1993, 114(2):376-390. 10.1037/0033-2909.114.2.376.
46. Mennin D.S., Ellard K.K., Fresco D.M., Gross J.J. United we stand: Emphasizing commonalities across cognitive-behavioral therapies. Behavior Therapy 2013, 44(2):234-248. 10.1016/j.beth.2013.02.004.
47. Mennin D.S., Heimberg R.G. The impact of comorbid mood and personality disorders in the cognitive-behavioral treatment of panic disorder. Clinical Psychology Review 2000, 20(3):339-357. 10.1016/s0272-7358(98)00095-6.
48. Meuret A.E., Hofmann S.G., Rosenfield D. Catastrophic appraisal and perceived control as moderators of treatment response in panic disorder. International Journal of Cognitive Therapy 2010, 3(3):262-277. 10.1521/ijct.2010.3.3.262.
49. Milrod B.L., Leon A.C., Barber J.P., Markowitz J.C., Graf E. Do comorbid personality disorders moderate panic-focused psychotherapy? An exploratory examination of the American Psychiatric Association practice guideline. The Journal of Clinical Psychiatry 2007, 68(6):885-891. 10.4088/jcp.v68n0610.
50. Mululo S.C.C., de Menezes G.B., Vigne P., Fontenelle L.F. A review on predictors of treatment outcome in social anxiety disorder. Revista Brasileira de Psiquiatria (São Paulo, Brazil: 1999) 2012, 34(1):92-100. 10.1016/s1516-4446(12)70016-8.
51. Newman M.G., Fisher A.J. Mediated moderation in combined cognitive behavioral therapy versus component treatments for generalized anxiety disorder. Journal of Consulting and Clinical Psychology 2013, 81(3):405-414. 10.1037/a0031690.
52. Niles A.N., Mesri B., Burklund L.J., Lieberman M.D., Craske M.G. Attentional bias and emotional reactivity as predictors and moderators of behavioral treatment for social phobia. Behaviour Research and Therapy 2013, 51(10):669-679. 10.1016/j.brat.2013.06.005.
53. Nilsen T.S., Eisemann M., Kvernmo S. Predictors and moderators of outcome in child and adolescent anxiety and depression: A systematic review of psychological treatment studies. European Child & Adolescent Psychiatry 2013, 22(2):69-87. 10.1007/s00787-012-0316-3.
54. Nordgreen T., Havik O.E., Öst L.G., Furmark T., Carlbring P., Andersson G. Outcome predictors in guided and unguided self-help for social anxiety disorder. Behaviour Research and Therapy 2012, 50(1):13-21. 10.1016/j.brat.2011.10.009.
55. Norton P.J., Price E.C. A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. The Journal of Nervous and Mental Disease 2007, 195(6):521-531. 10.1097/01.nmd.0000253843.70149.9a.
56. Olatunji B.O., Cisler J.M., Deacon B.J. Efficacy of cognitive behavioral therapy for anxiety disorders: A review of meta-analytic findings. Psychiatric Clinics of North America 2010, 33(3):557-577. 10.1016/j.psc.2010.04.002.
57. Olatunji B.O., Davis M.L., Powers M.B., Smits J.A.J. Cognitive-behavioral therapy for obsessive-compulsive disorder: A meta-analysis of treatment outcome and moderators. Journal of Psychiatric Research 2013, 47(1):33-41. 10.1016/j.jpsychires.2012.08.020.
58. Pampaloni I., Bruscoli M., Pallanti S. Obsessive-compulsive disorder: Clinical response predictors. Clinical Neuropsychiatry: Journal of Treatment Evaluation 2004, 1(1):52-58.
59. Pan D., Huey S.J., Hernandez D. Culturally adapted versus standard exposure treatment for phobic Asian Americans: Treatment efficacy, moderators, and predictors. Cultural Diversity and Ethnic Minority Psychology 2011, 17(1):11-22. 10.1037/a0022534.
60. Rodebaugh T.L., Heimberg R.G., Schultz L.T., Blackmore M. The moderated effects of video feedback for social anxiety disorder. Journal of Anxiety Disorders 2010, 24(7):663-671. 10.1016/j.janxdis.2010.04.007.
61. Simon G.E., Perlis R.H. Personalized medicine for depression: Can we match patients with treatments?. American Journal of Psychiatry 2010, 167(12):1445-1455. 10.1176/appi.ajp.2010.09111680.
62. Smits J.A.J., Hofmann S.G., Rosenfield D., DeBoer L.B., Costa P.T., Simon N.M., et al. d-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: Prognostic and prescriptive variables. Journal of Consulting and Clinical Psychology 2013, 10.1037/a0034120.
63. Solvason H.B., Ernst H., Roth W. Predictors of response in anxiety disorders. Psychiatric Clinics of North America 2003, 26(2):411-433. 10.1016/S0193-953X(03)00027-3.
64. Steketee G., Shapiro L.J. Predicting behavioral treatment outcome for agoraphobia and obsessive compulsive disorder. Clinical Psychology Review 1995, 15(4):317-346. 10.1016/0272-7358(95)00017-j.
65. Taylor S. Outcome predictors for three PTSD treatments: Exposure therapy, EMDR, and relaxation training. Journal of Cognitive Psychotherapy 2003, 17(2):149-162. 10.1891/088983903780906219.
66. Taylor S., Abramowitz J.S., McKay D. Non-adherence and non-response in the treatment of anxiety disorders. Journal of Anxiety Disorders 2012, 26(5):583-589. 10.1016/j.janxdis.2012.02.010.
67. Thrasher S., Power M., Morant N., Marks I., Dalgleish T. Social support moderates outcome in a randomized controlled trial of exposure therapy and (or) cognitive restructuring for chronic posttraumatic stress disorder. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 2010, 55(3):187-190.
68. Tolin D.F. Is cognitive-behavioral therapy more effective than other therapies? A meta-analytic review. Clinical Psychology Review 2010, 30(6):710-720. 10.1016/j.cpr.2010.05.003.
69. Tyrer P., Seivewright N., Ferguson B., Murphy S., Johnson A.L. The Nottingham study of neurotic disorder. Effect of personality status on response to drug treatment, cognitive therapy and self-help over two years. The British Journal of Psychiatry 1993, 162(2):219-226. 10.1192/bjp.162.2.219.
70. Walters K., Rait G., Griffin M., Buszewicz M., Nazareth I. Recent trends in the incidence of anxiety diagnoses and symptoms in primary care. PLoS ONE 2012, 7(8):e41670. 10.1371/journal.pone.0041670.
71. Westra H.A., Arkowitz H., Dozois D.J.A. Adding a motivational interviewing pretreatment to cognitive behavioral therapy for generalized anxiety disorder: A preliminary randomized controlled trial. Journal of Anxiety Disorders 2009, 23(8):1106-1117. 10.1016/j.janxdis.2009.07.014.
72. Wolitzky-Taylor K.B., Arch J.J., Rosenfield D., Craske M.G. Moderators and non-specific predictors of treatment outcome for anxiety disorders: A comparison of cognitive behavioral therapy to acceptance and commitment therapy. Journal of Consulting and Clinical Psychology 2012, 80(5):786-799. 10.1037/a0029418.
73. Zettle R.D. Acceptance and commitment therapy (ACT) vs. systematic desensitization in treatment of mathematics anxiety. The Psychological Record 2003, 53(2):197-215.